Deborah E. Sellmeyer, MD

Stanford University School of Medicine
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• ORF16-03 - Management of Refractory Hypercalcemia Due to Parathyromatosis

  Saturday, June 13, 2026
  1:55 PM - 2:00 PM CT

• SUN-815 - Management of Refractory Hypercalcemia Due to Parathyromatosis

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF34-04 - Association between Semaglutide and Risk of Bone Fractures in Type 2 Diabetes

  Sunday, June 14, 2026
  2:00 PM - 2:15 PM CT

• MON-806 - Blood cell count parameter changes following PTH analog treatment in a real-world case series

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT